Prescription Drug User Fee Act (PDUFA)
The Issue
The Prescription Drug User Fee Act (PDUFA), first enacted in 1992 and revised in 1997 and 2002, is a program under which the pharmaceutical/biotechnology industry pays certain "user fees" to the Food and Drug Administration (FDA). In return, the FDA has reduced the approval time for New Drug Application and Biological License Applications.
Our Position
We monitor the application of PDUFA at the FDA and support ongoing efforts to ensure quick but sufficient reviews of new drugs.
About MassBio
MassBio, founded in 1985, is a not-for-profit organization committed to advancing the development of critical new science, technology and medicines that benefit people worldwide.
Latest Updates
- March 10, 2010 Asterand announces 2010 Human Tissue Research Conference
- March 8, 2010 Biocell Center Corporation Partners with New England's Largest Community-Based Hospital Network to Offer a Unique Service in Amniotic Fluid Stem Cell Preservation
- March 8, 2010 LES Spring Meeting: Linking Entrepreneurship and Technology Commercialization
- March 5, 2010 MassBioEd Course: Four Day Leadership Training Program for Scientists
- March 2, 2010 JOULE NAMED AMONG 50 MOST INNOVATIVE COMPANIES IN THE WORLD